Vontobel Holding’s Novo Nordisk NVO Stock Holding History

Vontobel Holding’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.46M	Sell	113,956 -176,266	-61%	-$7.57M	0.02%	435
2026 Q1	$10.7M	Buy	290,222 +114,071	+65%	+$5.4M	0.04%	262
2025 Q4	$8.96M	Buy	176,151 +48,733	+38%	+$2.49M	0.03%	304
2025 Q3	$7.07M	Sell	127,418 -13,325	-9%	-$780K	0.02%	311
2025 Q2	$9.71M	Sell	140,743 -69,642	-33%	-$4.74M	0.03%	260
2025 Q1	$14.6M	Sell	210,385 -52,817	-20%	-$4.36M	0.05%	190
2024 Q4	$22.6M	Buy	263,202 +251,064	+2,068%	+$27.1M	0.08%	152
2024 Q3	$1.45M	Buy	12,138 +2,295	+23%	+$306K	﹤0.01%	518
2024 Q2	$1.4M	Buy	+9,843	New	+$1.3M	﹤0.01%	505
2023 Q3	–	Sell	-3,996	Closed	-$323K	–	1114
2023 Q2	$323K	Buy	+3,996	New	+$326K	﹤0.01%	903
2022 Q4	–	Sell	-5,434	Closed	-$271K	–	1111
2022 Q3	$271K	Buy	5,434 +238	+5%	+$12.8K	﹤0.01%	880
2022 Q2	$289K	Buy	+5,196	New	+$288K	﹤0.01%	853

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Vontobel Holding's NVO Position: Q2 2026 in Review

Vontobel Holding reduced its Novo Nordisk (NVO) stake by 61% in Q2 2026, selling an estimated $7.57M and leaving 113,956 shares worth $5.46M. The position accounts for 0.02% of the portfolio, ranked #435.

Vontobel Holding first reported a position in NVO in Q2 2022 and has held it in 12 quarters since. The position peaked at $22.6M in Q4 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Vontobel Holding held 113,956 shares of Novo Nordisk worth $5.46M as of Q2 2026.
Vontobel Holding sold 176,266 Novo Nordisk shares in Q2 2026, an estimated $7.57M.
Novo Nordisk made up 0.02% of Vontobel Holding's portfolio in Q2 2026, its #435 holding.
Vontobel Holding first reported a position in Novo Nordisk in Q2 2022 and has held it in 12 quarters since.
Vontobel Holding's Novo Nordisk position peaked at $22.6M in Q4 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.